Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 197,688 | 179,437 | 176,359 | 170,065 | 168,393 |
| Cost of Goods | 130,910 | 119,473 | 116,046 | 112,547 | 113,349 |
| Gross Profit | 66,778 | 59,964 | 60,313 | 57,518 | 55,044 |
| Operating Expenses | 12,592 | 16,066 | 986 | 12,107 | 13,493 |
| Operating Income | 55,096 | 44,371 | 59,373 | 45,958 | 41,900 |
| Interest Expense | 8,000 | 4,782 | 16,498 | 614 | 635 |
| Pre-tax Income | 47,096 | 39,589 | 42,875 | 45,344 | 41,265 |
| Income Tax | 14,652 | 12,739 | 17,139 | 13,830 | 12,462 |
| Net Income Continuous | 32,444 | 26,850 | 25,736 | 31,514 | 28,803 |
| Minority Interests | 77 | 103 | N/A | N/A | N/A |
| Net Income | $32,367 | $26,747 | $25,633 | $31,514 | $28,803 |
| EPS Basic Total Ops | 0.71 | 0.58 | 0.55 | 0.67 | 0.60 |
| EPS Basic Continuous Ops | 0.71 | 0.58 | 0.56 | 0.67 | 0.60 |
| EPS Diluted Total Ops | 0.66 | 0.56 | 0.53 | 0.65 | 0.59 |
| EPS Diluted Continuous Ops | 0.66 | 0.56 | 0.52 | 0.65 | 0.59 |
| EBITDA(a) | $60,372 | $49,610 | $64,708 | $51,354 | $47,165 |